Literature DB >> 7945288

Na(+)-dependent transport of aminopeptidase-resistant sugar-coupled tripeptides in rat intestine.

T Mizuma1, N Sakai, S Awazu.   

Abstract

Aminopeptidase-degradable tripeptide, tyrosylglycylglycine (TGG, a part of aminopeptidase-degradable enkephalines), was coupled with sugars (cellobiose, maltose, lactose, gentiobiose and glucose). These sugar-coupled TGGs were stable enough to be transported from the mucosal to the serosal side in rat everted small intestine, while TGG was not stable enough to be transported. The transport of sugar-coupled TGGs was decreased in the absence of Na+, indicating the Na(+)-dependent transport of sugar-coupled TGG in rat intestine. Cellobiose-coupled TGG and glucose-coupled TGG did not mutually inhibit their transport. It was suggested that the intestinal Na(+)-dependent transporter for disaccharide-coupled tripeptides, which have a pyranose ring, was different from that of monosaccharide-coupled tripeptide, which has no pyranose ring.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7945288     DOI: 10.1006/bbrc.1994.2342

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  4 in total

Review 1.  Important drug-nutrient interactions in the elderly.

Authors:  J A Thomas; R A Burns
Journal:  Drugs Aging       Date:  1998-09       Impact factor: 3.923

Review 2.  Carrier-mediated intestinal transport of drugs.

Authors:  A Tsuji; I Tamai
Journal:  Pharm Res       Date:  1996-07       Impact factor: 4.200

3.  (18)F-Fluoroglucosylation of peptides, exemplified on cyclo(RGDfK).

Authors:  Christina Hultsch; Margret Schottelius; Jörg Auernheimer; Andrea Alke; Hans-Jürgen Wester
Journal:  Eur J Nucl Med Mol Imaging       Date:  2009-04-07       Impact factor: 9.236

4.  The Metabolic Inhibition Model Which Predicts the Intestinal Absorbability and Metabolizability of Drug: Theory and Experiment.

Authors:  Takashi Mizuma; Shoji Awazu
Journal:  Biol Proced Online       Date:  1998-05-14       Impact factor: 3.244

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.